C. J. De Blaey
- Geriatrics and Gerontology top 0.5%
- Toxicology top 0.5%
- Pediatrics, Perinatology and Child Health top 5%
- Pharmaceutical Science top 2%
- Economics and Econometrics top 5%
- Co-authors
- H. J. M. BeijerDaan J.A. CrommelinTinca J. C. PoldermanJ. R. B. J. BrouwersR. FijnPatricia M. L. A. van den BemtL T W de Jong-van den BergMarcel L. Bouvy
- Topics
- Drug Solubulity and Delivery Systems (11 papers)Pharmaceutical studies and practices (10 papers)Crystallization and Solubility Studies (8 papers)
- Journals
- International Journal of PharmaceuticsPharmaceutical ResearchJournal of Pharmaceutical Sciences
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
C. J. De Blaey
45 papers receiving 940 citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Geriatrics and Gerontology 493
- Toxicology 236
- Pediatrics, Perinatology and Child Health 222
- Pharmaceutical Science 191
- Economics and Econometrics 165
Countries citing papers authored by C. J. De Blaey
This map shows the geographic impact of C. J. De Blaey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. J. De Blaey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. J. De Blaey more than expected).
Fields of papers citing papers by C. J. De Blaey
This network shows the impact of papers produced by C. J. De Blaey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. J. De Blaey. The network helps show where C. J. De Blaey may publish in the future.
Co-authorship network of co-authors of C. J. De Blaey
This figure shows the co-authorship network connecting the top 25 collaborators of C. J. De Blaey. A scholar is included among the top collaborators of C. J. De Blaey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. J. De Blaey. C. J. De Blaey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 18 | |
| 3 | 2 | |
| 4 | 8 | |
| 5 | 3 | |
| 6 | 17 | |
| 7 | 5 | |
| 8 | Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies.breakdown → | 532 |
| 9 | 86 | |
| 10 | 6 | |
| 11 | 4 | |
| 12 | 22 | |
| 13 | 4 | |
| 14 | 3 | |
| 15 | 3 | |
| 16 | 4 | |
| 17 | 9 | |
| 18 | 20 | |
| 19 | 27 | |
| 20 | 9 |
About C. J. De Blaey
C. J. De Blaey is a scholar working on Family Practice, Pharmaceutical Science and Geriatrics and Gerontology, having authored 47 papers that have together received 1.0k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (11 papers), Pharmaceutical studies and practices (10 papers) and Crystallization and Solubility Studies (8 papers). The work is most often cited by research in Geriatrics and Gerontology (493 citations), Toxicology (236 citations) and Family Practice (106 citations). C. J. De Blaey has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include H. J. M. Beijer, Daan J.A. Crommelin, Tinca J. C. Polderman, J. R. B. J. Brouwers, R. Fijn, Patricia M. L. A. van den Bemt, L T W de Jong-van den Berg, Marcel L. Bouvy, Anthonius de Boer and C. G. de Kruif. Their work appears in journals such as International Journal of Pharmaceutics, Pharmaceutical Research and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.